UCP2 and cancer: The inhibition of UCP2 allows ROS accumulation and genomic instability, while the negative regulation of mitochondrial ROS production through UCP2 over-expression usually occurs during cancer development, chemo-resistance, and tumor metastasis to defend cancer cells from apoptosis.